Patent · US Active

Compositions and methods for inducing HIV-1 antibodies

US11318197B2 · kind B2 · utility

1Cited by
4References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2018
Grant dateMay 3, 2022
Priority date
Expiry dateMar 2, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In certain aspects the invention provides HV-1 immunogens, including envelopes (CH0848) and selections therefrom, and methods for swarm immunizations using combinations of HIV-1 envelopes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.